APA (7th ed.) Citation

Richter, J., Neparidze, N., Zhang, L., Nair, S., Monesmith, T., Sundaram, R., . . . Dhodapkar, M. V. (2013). Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma. Blood, 121(3), 423-430. https://doi.org/10.1182/blood-2012-06-435503

Chicago Style (17th ed.) Citation

Richter, Joshua, Natalia Neparidze, Lin Zhang, Shiny Nair, Tamara Monesmith, Ranjini Sundaram, Fred Miesowicz, Kavita M. Dhodapkar, and Madhav V. Dhodapkar. "Clinical Regressions and Broad Immune Activation Following Combination Therapy Targeting Human NKT Cells in Myeloma." Blood 121, no. 3 (2013): 423-430. https://doi.org/10.1182/blood-2012-06-435503.

MLA (9th ed.) Citation

Richter, Joshua, et al. "Clinical Regressions and Broad Immune Activation Following Combination Therapy Targeting Human NKT Cells in Myeloma." Blood, vol. 121, no. 3, 2013, pp. 423-430, https://doi.org/10.1182/blood-2012-06-435503.